Sujal M. Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT), bought 50,100 shares at $3.60 ($181K) on 2022-03-03, disclosed to the SEC on 2022-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.60 | 50,000 | $180K | 99.4% |
| 2 | $10.00 | 100 | $1K | 0.6% |
| Total | $3.61 avg | 50,100 | $181K | 100% |
| Filing → |
| NAUT | BUY | 2025-03-21 | $77K | — | Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2024-03-07 | $154K | — | Filing → |